<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Approach to the child with lymphocytosis or lymphocytopenia
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Approach to the child with lymphocytosis or lymphocytopenia
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Approach to the child with lymphocytosis or lymphocytopenia
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Thomas D Coates, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Peter Newburger, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Alan G Rosmarin, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            May 01, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Lymphocytes are a subset of white blood cells (WBC) that form an integral part of the immune system. They facilitate the body's humoral and cellular immunity against foreign proteins and pathogens. An increase in circulating lymphocytes (lymphocytosis) can be seen following infections such as infectious mononucleosis and pertussis, or in lymphoproliferative disorders such as acute and chronic lymphocytic leukemia. A similar array of disorders can cause a decrease in lymphocyte counts (lymphocytopenia), although immunodeficiency states must also be considered, especially in infants and young children.
        </p>
        <p>
         The various causes of lymphocytosis and lymphocytopenia in children will be reviewed here. Information on acute lymphoblastic leukemia (ALL), neutrophilia, neutropenia, and lymphocytosis/lymphocytopenia in adults is presented separately.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          ALL
         </strong>
         – (See
         <a class="medical medical_review" href="/z/d/html/6244.html" rel="external">
          "Overview of the clinical presentation and diagnosis of acute lymphoblastic leukemia/lymphoma in children"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Neutrophilia
         </strong>
         – (See
         <a class="medical medical_review" href="/z/d/html/8381.html" rel="external">
          "Approach to the patient with neutrophilia"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Neutropenia
         </strong>
         – (See
         <a class="medical medical_review" href="/z/d/html/8375.html" rel="external">
          "Overview of neutropenia in children and adolescents"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Adults
         </strong>
         – (See
         <a class="medical medical_review" href="/z/d/html/104124.html" rel="external">
          "Approach to the adult with lymphocytosis or lymphocytopenia"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          DEFINITIONS AND NORMAL VALUES
         </span>
         <span class="headingEndMark">
          —
         </span>
         The absolute lymphocyte count (ALC) is equal to the product of the total white blood cell count (WBC) and the percentage of lymphocytes on the WBC differential:
        </p>
        <div class="formulaContainer">
         <div class="formula">
          <p>
           ALC  =  WBC (cells/microL)  x  percent lymphocytes  ÷  100
          </p>
         </div>
        </div>
        <p class="headingAnchor" id="H14776017">
         <span class="h2">
          Lymphocytosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         In individuals older than 12 years, lymphocytosis is defined as an ALC &gt;4000 cells/microL (also expressed as &gt;4000/mm
         <sup>
          3
         </sup>
         or &gt;4.0 x 10
         <sup>
          9
         </sup>
         /L). Levels of blood lymphocytes are higher in neonates and young children, who may have normal blood absolute lymphocyte counts as high as 8000/microL. While these definitions apply in general, increases in certain subpopulations of lymphocytes can be quite significant even though the normal value for total ALC has not been exceeded.
        </p>
        <p>
         However, chronic clonal proliferations of lymphocytes are vanishingly rare in children. Lymphocytosis is usually due to infectious causes  (
         <a class="graphic graphic_table graphicRef58246" href="/z/d/graphic/58246.html" rel="external">
          table 1
         </a>
         ) or chronic inflammatory states with relative neutropenia. When the possibility of malignancy is considered in adults, age and ALC are the best predictors of abnormal immunophenotype by flow cytometry. The ALC cutoff values are &gt;4.0 x 10
         <sup>
          9
         </sup>
         /L for patients over 67 years of age and 6.7 x 10
         <sup>
          9
         </sup>
         cells/L for patients between 50 and 67 years of age. Approximately 1.3 percent of individuals over 50 years of age will have an ALC &gt;4.0 x 10
         <sup>
          9
         </sup>
         , and 59 percent of these will have will have an abnormal immunophenotype [
         <a href="#rid1">
          1,2
         </a>
         ]. Causes of clonal lymphocytosis are discussed in detail separately.
        </p>
        <p class="headingAnchor" id="H14776024">
         <span class="h2">
          Lymphocytopenia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Lymphocytopenia has been variously defined in older children as an ALC &lt;1500 cells/microL. Infants normally have higher lymphocyte numbers, and lymphocytopenia is usually defined as an ALC &lt;4500 cells/microL in children under eight months of age [
         <a href="#rid3">
          3
         </a>
         ]. (See
         <a class="local">
          'Lymphocytopenia'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H14776031">
         <span class="h2">
          Lymphocyte subpopulations
         </span>
         <span class="headingEndMark">
          —
         </span>
         Circulating blood lymphocytes include populations of T cells, B cells, and natural killer (NK) cells. Their normal relative proportions in the blood are:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         T cells (eg, CD3
         <sup>
          +
         </sup>
         cells) – 60 to 80 percent
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         B cells (eg, CD20
         <sup>
          +
         </sup>
         cells) – 10 to 20 percent
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         NK cells (eg, CD56
         <sup>
          +
         </sup>
         cells) – 5 to 10 percent
        </p>
        <p>
        </p>
        <p>
         The normal relative proportions of T cell subtypes in the blood are:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Helper/inducer T cells (ie, CD4
         <sup>
          +
         </sup>
         T cells) – 60 to 70 percent
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Suppressor/cytotoxic T cells (ie, CD8
         <sup>
          +
         </sup>
         T cells) – 30 to 40 percent
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h2">
          Clonal versus reactive lymphocytosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Lymphocytosis can be either a reactive polyclonal proliferation or a clonal expansion.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Reactive lymphocytosis
         </strong>
         <strong>
          -
         </strong>
         This term refers to a polyclonal lymphocytosis in a patient without a history of a hematologic disorder, who has a medical condition likely to be associated with lymphocytosis, and in whom the lymphocyte count normalizes, or is expected to normalize, within less than two months after resolution of this condition. Examples are viral infection and pertussis.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clonal lymphocytosis
         </strong>
         – This term refers to lymphocytosis and an established diagnosis of an acute or chronic lymphoproliferative disorder. Examples are monoclonal B cell lymphocytosis (MBL), chronic lymphocytic leukemia (CLL), and lymphoproliferative disorders of large granular lymphocytes.
        </p>
        <p>
        </p>
        <p>
         While malignant expansions of lymphocytes are clonal, non-malignant clonal expansions of T cells and B cells are now recognized. These disorders can remain stable or can progress to malignancy. (See
         <a class="medical medical_review" href="/z/d/html/4513.html" rel="external">
          "Clinical features and diagnosis of chronic lymphocytic leukemia/small lymphocytic lymphoma", section on 'Monoclonal B cell lymphocytosis'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/16360.html" rel="external">
          "Clinical manifestations, pathologic features, and diagnosis of T cell large granular lymphocyte leukemia", section on 'T cell clonopathy of unknown significance'
         </a>
         .)
        </p>
        <p>
         Clonality in the malignant lymphoproliferative disorders is usually determined by the presence of one or more defining abnormalities:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         An abnormal karyotype characteristic of the disease in question, such as the chromosomal translocation t(12;21) seen in many cases of childhood ALL (see
         <a class="medical medical_review" href="/z/d/html/4484.html" rel="external">
          "Classification, cytogenetics, and molecular genetics of acute lymphoblastic leukemia/lymphoma"
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A clonal rearrangement of the immunoglobulin genes, as seen in various B cell lymphoma/leukemias (see
         <a class="medical medical_review" href="/z/d/html/4482.html" rel="external">
          "General aspects of cytogenetic analysis in hematologic malignancies"
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The presence of a single light chain (eg, either kappa or lambda, but not both) in the circulating lymphoid cells, as seen in B cell CLL (see
         <a class="medical medical_review" href="/z/d/html/4513.html" rel="external">
          "Clinical features and diagnosis of chronic lymphocytic leukemia/small lymphocytic lymphoma", section on 'Immunophenotype'
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A clonal rearrangement of the T cell receptor, as seen in various T cell leukemias, such as T cell LGL leukemia (see
         <a class="medical medical_review" href="/z/d/html/16360.html" rel="external">
          "Clinical manifestations, pathologic features, and diagnosis of T cell large granular lymphocyte leukemia", section on 'Immunophenotype'
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Malignant NK cell conditions, by definition, will not show clonal rearrangements of immunoglobulin genes or the T cell receptor. However, as in aggressive NK cell leukemia, they may show Epstein-Barr virus (EBV) clonally integrated into cellular DNA [
         <a href="#rid4">
          4
         </a>
         ] and/or may show clonal chromosomal abnormalities.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H6983587">
         <span class="h1">
          EVALUATION OF THE CHILD WITH LYMPHOCYTOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         A complete history and physical examination, together with a complete blood count (CBC) and examination of the peripheral blood smear are essential for initial evaluation of the child with lymphocytosis. In particular, one should determine if there is any history of recent infection that could explain the lymphocytosis.
        </p>
        <p>
         The differential diagnosis will depend on the age of the patient and the symptoms.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In children, presence of "atypical" or "viral" lymphocytes is quite common. The presence of significant lymphadenopathy or splenomegaly is suggestive of EBV infection, even in the absence of systemic symptoms. EBV serology is indicated in most cases of lymphocytosis in children and young adults.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The presence of anemia, thrombocytopenia, or neutropenia in conjunction with lymphocytosis is suggestive of a malignant process and warrants immediate referral to a hematologist. If the lymphocytosis is of moderate degree and present on repeated measurements over time, flow cytometry with lymphocyte subset analysis should be done. Hematologic consultation should be obtained.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h2">
          Blood lymphocyte morphology
         </span>
         <span class="headingEndMark">
          —
         </span>
         Reactive lymphocytosis can be confused with malignant lymphocytosis (ie, the various leukemic states) by an inexperienced observer viewing the Wright-Giemsa-stained blood smear. Certain phenotypic characteristics may suggest a reactive or a malignant cause of the lymphocytosis, which could be confirmed by additional testing.
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h3">
          Reactive lymphocytosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         In general, reactive lymphocytosis is due to the presence in the peripheral blood of one of two types of lymphocytes:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         An absolute increase in mature normal-appearing small lymphocytes, as seen in pertussis and infectious lymphocytosis  (
         <a class="graphic graphic_picture graphicRef62209" href="/z/d/graphic/62209.html" rel="external">
          picture 1
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         An absolute increase in larger lymphocytes with abundant basophilic cytoplasm and a large irregularly-shaped nucleus containing a rare nucleolus. Infectious mononucleosis during the second and third week of illness results in a marked increase in these larger forms of lymphocytes, so called "atypical", "transformed", or "lymph variants"  (
         <a class="graphic graphic_picture graphicRef55986" href="/z/d/graphic/55986.html" rel="external">
          picture 2
         </a>
         ). Similar findings can be seen in the other viral illnesses listed in the table  (
         <a class="graphic graphic_table graphicRef58246" href="/z/d/graphic/58246.html" rel="external">
          table 1
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h3">
          Malignant lymphocytosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         A number of different types of lymphoid cells may appear in the peripheral blood in the various malignant lymphoproliferative disorders. The early phases of B cell, T cell, or NK cell lymphoproliferative malignancies can mimic benign polyclonal or reactive lymphocytosis. Bone marrow, immunophenotyping, gene rearrangement studies, and/or cytogenetic studies are required to differentiate chronic lymphocytic leukemia or, sometimes, T cell leukemia from benign lymphocytosis.
        </p>
        <p>
         Particularly in infants and very young children, normal peripheral lymphocytes can appear immature and can be mistaken for lymphoblasts by individuals not accustomed to looking at pediatric blood smears. Similarly, bone marrows of young children can contain hematogones (ie, normal maturing B cell precursors) that look immature and can be difficult to distinguish morphologically from lymphocytic leukemia blasts. They can be identified on flow cytometry. Hematogones comprise up to 6.4 percent of peripheral lymphocytes in 60 percent of infants less than one month of age [
         <a href="#rid5">
          5
         </a>
         ], and can comprise 0.01 to 1.3 percent of WBCs in adults by sensitive flow cytometry methods [
         <a href="#rid6">
          6,7
         </a>
         ].
        </p>
        <p>
         Usually by the time the child has evidence of significant malignant lymphocytosis, there are other findings in the blood count (eg, anemia, neutropenia, thrombocytopenia) that suggest the diagnosis of leukemia. Complaints of bone pain, especially back or hip pain, which are very uncommon in children, as well as lymphadenopathy or hepatosplenomegaly, are other worrisome findings in the face of lymphocytosis. Malignant disorders of lymphocytes are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/6244.html" rel="external">
          "Overview of the clinical presentation and diagnosis of acute lymphoblastic leukemia/lymphoma in children"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4686.html" rel="external">
          "Clinical manifestations, pathologic features, and diagnosis of B cell acute lymphoblastic leukemia/lymphoma"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4489.html" rel="external">
          "Staging and prognosis of chronic lymphocytic leukemia"
         </a>
         .)
        </p>
        <p>
         Some lymphoid malignancies may have varying numbers of lymphoid cells in the peripheral blood as part of the disease process. While they may be distinctive enough to suggest the underlying diagnosis, this is a very uncommon presentation in pediatric lymphoid malignancies other than leukemia.
        </p>
        <p>
         Lymphoblasts in acute lymphoblastic leukemia (ALL) can have varied morphologies where the blasts have essentially no cytoplasm  (
         <a class="graphic graphic_picture graphicRef57831" href="/z/d/graphic/57831.html" rel="external">
          picture 3
         </a>
         ), abundant bluish cytoplasm, or deep blue cytoplasm of Burkitt type lymphoblasts  (
         <a class="graphic graphic_picture graphicRef57366" href="/z/d/graphic/57366.html" rel="external">
          picture 4
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/4686.html" rel="external">
          "Clinical manifestations, pathologic features, and diagnosis of B cell acute lymphoblastic leukemia/lymphoma", section on 'Morphology'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4435.html" rel="external">
          "Evaluation of the peripheral blood smear", section on 'Worrisome findings'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h1">
          CAUSES OF REACTIVE LYMPHOCYTOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The usual cause of reactive lymphocytosis is one of a variety of viral infections, most frequently observed in children and young adults  (
         <a class="graphic graphic_table graphicRef58246" href="/z/d/graphic/58246.html" rel="external">
          table 1
         </a>
         ).
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h2">
          Infectious mononucleosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Epstein-Barr virus (EBV) is the major cause of infectious mononucleosis, which is associated with a marked reactive "atypical" lymphocytosis  (
         <a class="graphic graphic_picture graphicRef55986" href="/z/d/graphic/55986.html" rel="external">
          picture 2
         </a>
         ). These atypical lymphocytes peak during the second and third week of illness, and persist for as long as two months [
         <a href="#rid8">
          8,9
         </a>
         ]. Oral shedding of virus continues for a median of 174 days and viremia for as long as 90 days in college students [
         <a href="#rid10">
          10
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/8318.html" rel="external">
          "Infectious mononucleosis", section on 'Transmission'
         </a>
         .)
        </p>
        <p>
         Although EBV infects B lymphocytes, the reactive lymphocytosis in the blood is due to absolute increases in T-lymphocytes, predominately of the CD8
         <sup>
          +
         </sup>
         subtype [
         <a href="#rid10">
          10
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/8318.html" rel="external">
          "Infectious mononucleosis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H9">
         <span class="h2">
          Mononucleosis syndrome
         </span>
         <span class="headingEndMark">
          —
         </span>
         A clinical picture resembling infectious mononucleosis (mononucleosis syndrome) may be caused by a number of infectious agents other than EBV. The two most important entities to include in the differential diagnosis of the mononucleosis syndrome are infections with cytomegalovirus (CMV) and the human immunodeficiency virus (HIV-1).
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Cytomegalovirus (CMV), in a substantial minority of cases, causes the infectious mononucleosis syndrome [
         <a href="#rid11">
          11
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/8289.html" rel="external">
          "Epidemiology, clinical manifestations, and treatment of cytomegalovirus infection in immunocompetent adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         During primary infection with HIV-1, patients may present with a mononucleosis syndrome. This presentation of primary HIV infection is occasionally associated with a concomitant CMV infection [
         <a href="#rid12">
          12-14
         </a>
         ]. In primary HIV the peripheral blood lymphocytosis has an immunophenotype pattern of CD3+/CD8+ (ie, suppressor/cytotoxic T cells) [
         <a href="#rid15">
          15
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/3752.html" rel="external">
          "Acute and early HIV infection: Pathogenesis and epidemiology"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3724.html" rel="external">
          "The natural history and clinical features of HIV infection in adults and adolescents"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Other infections have been implicated as occasional etiologies of the mononucleosis syndrome, including human herpesvirus type 6 [
         <a href="#rid16">
          16
         </a>
         ], adenovirus type 12 [
         <a href="#rid17">
          17
         </a>
         ], and toxoplasmosis [
         <a href="#rid18">
          18
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H10">
         <span class="h2">
          Other viral illnesses
         </span>
         <span class="headingEndMark">
          —
         </span>
         Human T-lymphotropic virus type I (HTLV-I) infection has resulted in a self-limited immature T cell lymphocytosis as high as 20,000/microL, evolving into a mature T cell lymphocytosis with a CD4/CD8 ratio of 4.5:1 [
         <a href="#rid19">
          19
         </a>
         ]. Patients with mumps, varicella, influenza, hepatitis, rubella, or measles infections usually have reactive lymphocytosis as a feature of their illness [
         <a href="#rid20">
          20
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H11">
         <span class="h3">
          Infectious lymphocytosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         A number of viruses including coxsackie virus B2, poliovirus, and other enteroviruses, have been associated with a benign condition called infectious lymphocytosis in children [
         <a href="#rid21">
          21-23
         </a>
         ]. Affected patients have total white blood cell counts ranging from 20,000 to 100,000/microL with 60 to 90 percent small mature T-lymphocytes [
         <a href="#rid21">
          21-23
         </a>
         ]. The illness is often accompanied by mild eosinophilia and subsides over 4 to 10 weeks. The diagnosis is usually made by chance when a blood test is performed. Most patients are asymptomatic, although fever, respiratory signs and symptoms, diarrhea or abdominal pain, and rarely meningoencephalitis or morbilliform rash may occur [
         <a href="#rid21">
          21,22
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H12">
         <span class="h2">
          Pertussis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Acute bacterial infections rarely produce lymphocytosis, except for pertussis (whooping cough), due to infection with Bordetella pertussis. In one study of 11 children, the absolute lymphocyte count ranged from 6500 to 54,800/microL, with a mean of 20,300/microL [
         <a href="#rid24">
          24
         </a>
         ]. Buffy coat smears revealed a significant increase in small lymphocytes with convoluted and cleaved nuclei; mean percentages of circulating WBC were 21 percent B cells and 53 percent T cells (ie, normal percentages by immunophenotype) [
         <a href="#rid24">
          24
         </a>
         ].This increase in lymphocyte numbers appears to result from a block in the normal extravasation of lymphocytes from the blood into lymph nodes rather than an increase in lymphocyte production.
        </p>
        <p>
         By contrast, when an identical clinical illness is caused by B. parapertussis, lymphocytosis is not observed. In one study of 114 patients, 38 of whom had B. parapertussis infection and the remainder B. pertussis, the mean leukocyte and lymphocyte counts were significantly lower in the former infection (7600 versus 12,500/microL and 3500 versus 7800/microL, respectively) [
         <a href="#rid25">
          25
         </a>
         ]. Both B. pertussis and B. parapertussis express pertussis toxin; B. pertussis also appears to produce a lymphocytosis-promoting factor toxin [
         <a href="#rid25">
          25
         </a>
         ].
        </p>
        <p>
         While the presence of lymphocytosis is not very specific for the diagnosis of pertussis, the absence of lymphocytosis makes pertussis unlikely [
         <a href="#rid26">
          26
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/8045.html" rel="external">
          "Pertussis infection in adolescents and adults: Clinical manifestations and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5995.html" rel="external">
          "Pertussis infection in infants and children: Clinical features and diagnosis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H13">
         <span class="h2">
          Cat scratch disease and other chronic bacterial infections
         </span>
         <span class="headingEndMark">
          —
         </span>
         Bartonella henselae causes cat scratch disease, characterized by solitary lymphadenopathy and systemic signs and symptoms of chronic inflammation. Large atypical lymphocytes may be seen on the blood smear, usually with mild eosinophilia and monocytosis, anemia, or thrombocytopenia [
         <a href="#rid27">
          27
         </a>
         ]. Other systemic chronic infections such as rickettsial infection, tuberculosis, brucellosis, and syphilis often show a similar blood picture. (See
         <a class="medical medical_review" href="/z/d/html/5532.html" rel="external">
          "Microbiology, epidemiology, clinical manifestations, and diagnosis of cat scratch disease"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H14">
         <span class="h2">
          Toxoplasmosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Toxoplasmosis usually produces an asymptomatic infection or lymphadenopathy in immunocompetent patients but may cause disseminated manifestations in immunocompromised hosts. The lymphadenopathy involves multiple lymph node sites and, in one-third of cases, there is associated hepatosplenomegaly. As noted above, the hematologic picture may produce the mononucleosis syndrome (ie, mimic that seen in infectious mononucleosis), with lymphocytosis and large reactive atypical lymphocytes; eosinophilia occurs in 10 to 20 percent of cases [
         <a href="#rid18">
          18,28
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H15">
         <span class="h2">
          Babesiosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Babesiosis is a tick-borne disease caused by Babesia microti in the United States; it is endemic in Martha's Vineyard, Nantucket, and Long Island. It is also caused by Babesia divergens in Europe. (See
         <a class="medical medical_review" href="/z/d/html/5734.html" rel="external">
          "Babesiosis: Microbiology, epidemiology, and pathogenesis"
         </a>
         .)
        </p>
        <p>
         As is true for Plasmodium parasites, Babesia infects red blood cells, causing hemolytic anemia; clinical manifestations closely resemble malaria. The organisms can be seen on blood smear  (
         <a class="graphic graphic_picture graphicRef110026" href="/z/d/graphic/110026.html" rel="external">
          picture 5
         </a>
         and
         <a class="graphic graphic_picture graphicRef131054" href="/z/d/graphic/131054.html" rel="external">
          picture 6
         </a>
         ), which also reveals up to 15 percent atypical lymphocytes [
         <a href="#rid29">
          29-31
         </a>
         ]. However, the total white blood count is not elevated. (See
         <a class="medical medical_review" href="/z/d/html/5670.html" rel="external">
          "Babesiosis: Clinical manifestations and diagnosis", section on 'Clinical manifestations'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H16">
         <span class="h2">
          Non-infectious causes
         </span>
         <span class="headingEndMark">
          —
         </span>
         Hypersensitivity reactions and stress are the most common etiologies of non-infectious reactive lymphocytosis.
        </p>
        <p class="headingAnchor" id="H17">
         <span class="h3">
          Hypersensitivity reactions
         </span>
         <span class="headingEndMark">
          —
         </span>
         Hypersensitivity reactions are either drug-induced or related to acute serum sickness. Drug-induced hypersensitivity syndromes usually occur two to six weeks after starting the drug, and consist of fever, leukocytosis with eosinophilia, and atypical lymphocytosis. These reactions can progress to multi-organ failure. These reactions can be related to certain HLA types, are associated more commonly with certainly classes of drugs such as anticonvulsants, and can have a mortality of up to 10 percent [
         <a href="#rid32">
          32,33
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/2086.html" rel="external">
          "Drug hypersensitivity: Classification and clinical features"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H18">
         <span class="h3">
          Stress-induced lymphocytosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Transient atypical lymphocytosis with absolute lymphocyte counts ranging from 4000 to 13,000/microL, often followed by neutrophilia, was observed in a group of 73 adults aged 43 to 93 years with cardiac emergencies, trauma, or status epilepticus [
         <a href="#rid34">
          34
         </a>
         ]. Their mortality rate was 50 percent, and the altered blood picture was ascribed either to stress or to administration of epinephrine. In a study of over 45,000 adult inpatients, lymphocytosis by itself, independent of trauma, predicted a threefold increased risk of death within 30 days of admission [
         <a href="#rid35">
          35
         </a>
         ]. The mechanism appears to be redistribution of lymphocytes induced by epinephrine [
         <a href="#rid36">
          36
         </a>
         ].
        </p>
        <p>
         The presence of lymphocytosis after trauma appears to be an early recognition sign of the high risk patient [
         <a href="#rid37">
          37
         </a>
         ]. Another emergency department study of 10 adults in sickle cell anemia crisis and 15 others with trauma or serious acute medical conditions and absolute lymphocytosis demonstrated increases in the numbers of CD20+ B cells, as well as T cells of the CD3, CD4, CD8, and CD56 phenotypes [
         <a href="#rid38">
          38
         </a>
         ]. These findings mimicked the effects of parenteral epinephrine administration: a pan-B and pan-T lymphocytosis with marked increase in CD56 (four- to fivefold) and CD8 cells (three- to fourfold), as well as moderate increases in CD20 and CD4 cells (twofold) [
         <a href="#rid38">
          38,39
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H20">
         <span class="h3">
          Postsplenectomy lymphocytosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Following splenectomy, most patients demonstrate an increase in circulating large granular lymphocytes [
         <a href="#rid40">
          40,41
         </a>
         ]. In one series of 23 patients, most of whom had Hodgkin lymphoma, splenectomy was associated with lymphocytosis in 20; the absolute lymphocyte counts ranged from 4000 to 8700/microL [
         <a href="#rid40">
          40
         </a>
         ]. The lymphocytosis persisted almost unchanged during a median follow-up of 50 months. Some patients have typical large granular lymphocyte morphology with primary expansion of NK cells [
         <a href="#rid41">
          41
         </a>
         ]. In vitro natural killer and antibody dependent cellular cytotoxic activities remain normal [
         <a href="#rid42">
          42
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H22">
         <span class="h1">
          LYMPHOPROLIFERATIVE DISORDERS
         </span>
         <span class="headingEndMark">
          —
         </span>
         A number of lymphoproliferative disorders are associated with peripheral lymphocytosis. In their early stages, it may be difficult to distinguish them from cases of reactive lymphocytosis. Serial blood counts may be necessary in order to differentiate between these two possibilities. However, the presence of blast forms (ie, lymphoblasts) and/or lymphocyte counts &gt;20,000/microL should prompt immediate referral to a hematologist. Some of these are discussed in this section.
        </p>
        <p class="headingAnchor" id="H495637">
         <span class="h2">
          Hereditary polyclonal B cell lymphocytosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients within the same family have presented in infancy with white cell counts in the 30,000 range with 85 percent lymphocytes and splenomegaly due to polyclonal B cells [
         <a href="#rid43">
          43,44
         </a>
         ]. The lymphocytosis persisted throughout childhood and became indistinguishable from chronic lymphocytic leukemia (CLL) by the fourth decade of life. (See
         <a class="medical medical_review" href="/z/d/html/104124.html" rel="external">
          "Approach to the adult with lymphocytosis or lymphocytopenia"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H25">
         <span class="h2">
          Lymphoproliferative disease of large granular lymphocytes
         </span>
         <span class="headingEndMark">
          —
         </span>
         Lymphoproliferative disease of the large granular lymphocyte is a relatively rare atypical lymphocytosis characterized by the presence in the blood of &gt;2000/microL large lymphocytes with slightly eccentric nuclei and abundant pale-blue cytoplasm containing many azurophilic granules  (
         <a class="graphic graphic_picture graphicRef69027" href="/z/d/graphic/69027.html" rel="external">
          picture 7
         </a>
         ) [
         <a href="#rid45">
          45
         </a>
         ]. Phenotypically these cells can be divided into expansions of CD3+/CD8+/CD4- T cells or CD3-/CD56+ NK cells that are usually clonal [
         <a href="#rid46">
          46,47
         </a>
         ]. These patients rarely may present in childhood but usually present in the fourth or fifth decade of life with autoimmune manifestations and neutropenia. While they can have absolute lymphocytosis, they can also have normal total lymphocytes with an increased percent of cytotoxic lymphocytes [
         <a href="#rid48">
          48-50
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/4536.html" rel="external">
          "Treatment of large granular lymphocyte leukemia"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4538.html" rel="external">
          "Natural killer (NK) cell large granular lymphocyte leukemia"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H24366655">
         <span class="h1">
          LYMPHOCYTOPENIA
         </span>
         <span class="headingEndMark">
          —
         </span>
         The causes of lymphocytopenia (ie, an absolute lymphocyte count &lt;1500/microL in older children or adults, &lt;4500/microL in infants) are various and include, among others, infection, iatrogenic causes, systemic disease, and congenital immunodeficiency disorders. A partial list of these causes is presented in the table  (
         <a class="graphic graphic_table graphicRef58469" href="/z/d/graphic/58469.html" rel="external">
          table 2
         </a>
         ).
        </p>
        <p>
         Lymphocytopenia in hospitalized patients is most frequently reversible. This was shown in a study of 1042 adults with an absolute lymphocyte count &lt;600/microL who were identified over a 102-day period in a single teaching hospital. For the 698 patients who had previous and subsequent blood counts, lymphocytopenia was consistently present in only 6 percent [
         <a href="#rid51">
          51
         </a>
         ]. The most common causes for lymphocytopenia in this report were:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Bacterial or fungal sepsis – 24 percent
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Postoperative state – 22 percent
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Malignancy – 17 percent
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Use of glucocorticoids – 15 percent
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Cytotoxic chemotherapy and/or radiation therapy – 9 percent
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Trauma or hemorrhage – 8 percent
        </p>
        <p>
        </p>
        <p>
         The main management of isolated persistent lymphocytopenia is observation. If no other cell lines are involved; there are no symptoms; and no history of infections, mouth sores or rheumatological issues, we would follow clinically with serial blood counts. Evaluation for HIV and infections noted in the table  (
         <a class="graphic graphic_table graphicRef58469" href="/z/d/graphic/58469.html" rel="external">
          table 2
         </a>
         ) should be performed. However, in the majority of cases there are likely to be some symptoms that would direct the evaluation. In the absence of any features to guide the diagnostic evaluation, the next step would be to evaluate for immunodeficiency. (See
         <a class="medical medical_review" href="/z/d/html/3914.html" rel="external">
          "Primary humoral immunodeficiencies: An overview"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3935.html" rel="external">
          "Combined immunodeficiencies: An overview"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4312262">
         <span class="h2">
          Reductions in lymphocyte subsets
         </span>
         <span class="headingEndMark">
          —
         </span>
         In addition to a reduction in the total number of circulating lymphocytes, a deficiency of one or more lymphocyte subsets may occur (eg, B cells, T cells, NK cells), and can be characteristic of a number of specific disorders, such as the primary or secondary immunodeficiency states. Patients with immunodeficiency may present with a range of disorders, such as:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Recurrent infections
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Autoimmune disorders
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Inflammatory disorders (eg, inflammatory bowel disease, inflammatory arthritis)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Malignancies (eg, lymphoma)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Allergic disease (eg, atopic dermatitis, food allergy, allergic rhinosinusitis, asthma)
        </p>
        <p>
        </p>
        <p>
         The approach to patients suspected of having a primary immunodeficiency is described separately. (See
         <a class="medical medical_review" href="/z/d/html/3903.html" rel="external">
          "Laboratory evaluation of the immune system", section on 'Initial approach to the patient'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3903.html" rel="external">
          "Laboratory evaluation of the immune system", section on 'Defects in cellular immunity'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H14776038">
         <span class="h1">
          SUMMARY
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Absolute lymphocyte count (ALC)
         </strong>
         – ALC is calculated as follows:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         ALC = white blood cells (WBC) x percent lymphocytes ÷ 100
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Lymphocytosis
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Children &gt;12 years
         </strong>
         – For children &gt;12 years, lymphocytosis is defined as ALC &gt;4000 cells/microL (&gt;4.0 x 10
         <sup>
          9
         </sup>
         /L).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Younger children
         </strong>
         – Levels of circulating lymphocytes are higher in neonates and young children (eg, normal ALC up to 8000/microL).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Causes of lymphocytosis
         </strong>
         – Lymphocytosis can be a reactive process or by a clonal disorder (ie, a lymphoproliferative malignancy).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Reactive
         </strong>
         – In children, the most common reason for reactive lymphocytosis is an infection, including viral, bacterial, and other agents  (
         <a class="graphic graphic_table graphicRef58246" href="/z/d/graphic/58246.html" rel="external">
          table 1
         </a>
         ). Less commonly, lymphocytosis is associated with a hypersensitivity reaction, autoimmune/rheumatologic illnesses, stress, thyroid disease, and other causes. (See
         <a class="local">
          'Causes of reactive lymphocytosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Malignant
         </strong>
         – In children, malignant lymphocytosis can be caused by acute lymphoblastic leukemia/lymphoblastic lymphoma, large granular lymphocytosis, and others. (See
         <a class="medical medical_review" href="/z/d/html/6244.html" rel="external">
          "Overview of the clinical presentation and diagnosis of acute lymphoblastic leukemia/lymphoma in children"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/16360.html" rel="external">
          "Clinical manifestations, pathologic features, and diagnosis of T cell large granular lymphocyte leukemia"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Initial evaluation
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Clinical
         </strong>
         – History and physical examination should evaluate recent infections and note lymphadenopathy and hepatosplenomegaly. (See
         <a class="local">
          'Evaluation of the child with lymphocytosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Complete blood count (CBC) with differential count
         </strong>
         – Assess abnormalities of erythrocytes, other myeloid cells, and platelets and calculate ALC.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Blood smear
         </strong>
         – The blood smear should note the presence of atypical lymphocytes (large lymphocytes with abundant basophilic cytoplasm and a large irregularly-shaped nucleus)  (
         <a class="graphic graphic_picture graphicRef55986" href="/z/d/graphic/55986.html" rel="external">
          picture 2
         </a>
         ), lymphoblasts  (
         <a class="graphic graphic_picture graphicRef57831" href="/z/d/graphic/57831.html" rel="external">
          picture 3
         </a>
         ), large granular lymphocytes  (
         <a class="graphic graphic_picture graphicRef69027" href="/z/d/graphic/69027.html" rel="external">
          picture 7
         </a>
         ), and other findings of lymphocytes or other lineages. (See
         <a class="local">
          'Blood lymphocyte morphology'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Further evaluation
         </strong>
         – Additional evaluation should be individualized, based on clinical and laboratory findings.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Worrisome features
         </strong>
         – Referral to a pediatric hematologist for a bone marrow aspirate or other specialized testing should be considered for features consistent with a hematologic malignancy. Examples include ALC &gt;20,000/microL, progressive rise of ALC, lymphoblasts, or abnormalities in other blood lineages.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Others
         </strong>
         – For children who are clinically stable with none of the features above, we monitor ALC with serial CBCs.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Lymphocytopenia
         </strong>
         – There is no consensus, but we define lymphocytopenia as:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Infants
         </strong>
         – ALC &lt;4500/microL in children less than 8 months
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Others
         </strong>
         – ALC &lt;1500 cells/microL
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Causes of lymphocytopenia
         </strong>
         – Causes include congenital immunodeficiency disorders, infection, iatrogenic causes, and systemic disease  (
         <a class="graphic graphic_table graphicRef58469" href="/z/d/graphic/58469.html" rel="external">
          table 2
         </a>
         ). (See
         <a class="local">
          'Lymphocytopenia'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2062756322">
         <span class="h1">
          ACKNOWLEDGMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         The editorial staff at UpToDate acknowledge Laurence A Boxer, MD, now deceased, who contributed to an earlier version of this topic review.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Carney D. Peripheral blood lymphocytosis--what is the threshold for further investigation? Leuk Lymphoma 2008; 49:1659.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Andrews JM, Cruser DL, Myers JB, et al. Using peripheral smear review, age and absolute lymphocyte count as predictors of abnormal peripheral blood lymphocytoses diagnosed by flow cytometry. Leuk Lymphoma 2008; 49:1731.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Régent A, Kluger N, Bérezné A, et al. [Lymphocytopenia: aetiology and diagnosis, when to think about idiopathic CD4(+) lymphocytopenia?]. Rev Med Interne 2012; 33:628.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kanegane H, Yachie A, Miyawaki T, Tosato G. EBV-NK cells interactions and lymphoproliferative disorders. Leuk Lymphoma 1998; 29:491.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brady KA, Atwater SK, Lowell CA. Flow cytometric detection of CD10 (cALLA) on peripheral blood B lymphocytes of neonates. Br J Haematol 1999; 107:712.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chantepie SP, Salaün V, Parienti JJ, et al. Hematogones: a new prognostic factor for acute myeloblastic leukemia. Blood 2011; 117:1315.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sevilla DW, Colovai AI, Emmons FN, et al. Hematogones: a review and update. Leuk Lymphoma 2010; 51:10.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Downey H, McKinlay CA. Acute lymphadenosis compared with acute lymphatic leukemia. Arch Intern Med 1923; 32:82.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vetsika EK, Callan M. Infectious mononucleosis and Epstein-Barr virus. Expert Rev Mol Med 2004; 6:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Balfour HH Jr, Odumade OA, Schmeling DO, et al. Behavioral, virologic, and immunologic factors associated with acquisition and severity of primary Epstein-Barr virus infection in university students. J Infect Dis 2013; 207:80.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Horwitz CA, Henle W, Henle G, et al. Clinical and laboratory evaluation of cytomegalovirus-induced mononucleosis in previously healthy individuals. Report of 82 cases. Medicine (Baltimore) 1986; 65:124.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Steeper TA, Horwitz CA, Hanson M, et al. Heterophil-negative mononucleosis-like illnesses with atypical lymphocytosis in patients undergoing seroconversions to the human immunodeficiency virus. Am J Clin Pathol 1988; 90:169.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Buchanan JG, Goldwater PN, Somerfield SD, Tobias MI. Mononucleosis-like-syndrome associated with acute AIDS retrovirus infection. N Z Med J 1986; 99:405.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zambello R, Trentin L, Agostini C, et al. Persistent polyclonal lymphocytosis in human immunodeficiency virus-1-infected patients. Blood 1993; 81:3015.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cooper DA, Gold J, Maclean P, et al. Acute AIDS retrovirus infection. Definition of a clinical illness associated with seroconversion. Lancet 1985; 1:537.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Steeper TA, Horwitz CA, Ablashi DV, et al. The spectrum of clinical and laboratory findings resulting from human herpesvirus-6 (HHV-6) in patients with mononucleosis-like illnesses not resulting from Epstein-Barr virus or cytomegalovirus. Am J Clin Pathol 1990; 93:776.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Horwitz CA, Henle W, Henle G, et al. Heterophil-negative infectious mononucleosis and mononucleosis-like illnesses. Laboratory confirmation of 43 cases. Am J Med 1977; 63:947.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Remington JS. Toxoplasmosis in the adult. Bull N Y Acad Med 1974; 50:211.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ehrlich GD, Han T, Bettigole R, et al. Human T-lymphotropic virus type I-associated benign transient immature T-cell lymphocytosis. Am J Hematol 1988; 27:49.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shiftan TA, Mendelsohn J. The circulating "atypical" lymphocyte. Hum Pathol 1978; 9:51.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Smith CH. Infectious lymphocytosis. Am J Dis Child 1941; 62:231.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           OLSON LC, MILLER G, HANSHAW JB. ACUTE INFECTIOUS LYMPHOCYTOSIS PRESENTING AS A PERTUSSIS-LIKE ILLNESS: ITS ASSOCIATION WITH ADENOVIRUS TYPE 12. Lancet 1964; 1:200.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cassuto JP, Schneider M, Bourg M, et al. Acute infectious lymphocytosis as a T-cell lymphoproliferative syndrome. Br Med J 1977; 2:1331.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kubic VL, Kubic PT, Brunning RD. The morphologic and immunophenotypic assessment of the lymphocytosis accompanying Bordetella pertussis infection. Am J Clin Pathol 1991; 95:809.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Heininger U, Stehr K, Schmitt-Grohé S, et al. Clinical characteristics of illness caused by Bordetella parapertussis compared with illness caused by Bordetella pertussis. Pediatr Infect Dis J 1994; 13:306.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Levene I, Wacogne I. Question 3. Is measurement of the lymphocyte count useful in the investigation of suspected pertussis in infants? Arch Dis Child 2011; 96:1203.
          </a>
         </li>
         <li class="breakAll">
          Margileth AM. Cat scratch disease. In: Nelson Textbook of Pediatrics, 15th ed, Behrman RE, Kliegman RM, Arvin AM (Eds), WB Saunders, Philadelphia 1996.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Saadatnia G, Golkar M. A review on human toxoplasmosis. Scand J Infect Dis 2012; 44:805.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rosenbaum GS, Johnson DH, Cunha BA. Atypical lymphocytosis in babesiosis. Clin Infect Dis 1995; 20:203.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mosqueda J, Olvera-Ramirez A, Aguilar-Tipacamu G, Canto GJ. Current advances in detection and treatment of babesiosis. Curr Med Chem 2012; 19:1504.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Perkins HA, Busch MP. Transfusion-associated infections: 50 years of relentless challenges and remarkable progress. Transfusion 2010; 50:2080.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pavlos R, Mallal S, Phillips E. HLA and pharmacogenetics of drug hypersensitivity. Pharmacogenomics 2012; 13:1285.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kano Y, Shiohara T. The variable clinical picture of drug-induced hypersensitivity syndrome/drug rash with eosinophilia and systemic symptoms in relation to the eliciting drug. Immunol Allergy Clin North Am 2009; 29:481.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Teggatz JR, Parkin J, Peterson L. Transient atypical lymphocytosis in patients with emergency medical conditions. Arch Pathol Lab Med 1987; 111:712.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kho AN, Hui S, Kesterson JG, McDonald CJ. Which observations from the complete blood cell count predict mortality for hospitalized patients? J Hosp Med 2007; 2:5.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Toft P, Tønnesen E, Svendsen P, et al. The redistribution of lymphocytes during adrenaline infusion. An in vivo study with radiolabelled cells. APMIS 1992; 100:593.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pinkerton PH, McLellan BA, Quantz MC, Robinson JB. Acute lymphocytosis after trauma--early recognition of the high-risk patient? J Trauma 1989; 29:749.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Groom DA, Kunkel LA, Brynes RK, et al. Transient stress lymphocytosis during crisis of sickle cell anemia and emergency trauma and medical conditions. An immunophenotyping study. Arch Pathol Lab Med 1990; 114:570.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mills PJ, Berry CC, Dimsdale JE, et al. Lymphocyte subset redistribution in response to acute experimental stress: effects of gender, ethnicity, hypertension, and the sympathetic nervous system. Brain Behav Immun 1995; 9:61.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Juneja S, Januszewicz E, Wolf M, Cooper I. Post-splenectomy lymphocytosis. Clin Lab Haematol 1995; 17:335.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Garcia-Suarez J, Prieto A, Reyes E, et al. Persistent lymphocytosis of natural killer cells in autoimmune thrombocytopenic purpura (ATP) patients after splenectomy. Br J Haematol 1995; 89:653.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kelemen E, Gergely P, Lehoczky D, et al. Permanent large granular lymphocytosis in the blood of splenectomized individuals without concomitant increase of in vitro natural killer cell cytotoxicity. Clin Exp Immunol 1986; 63:696.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Snow AL, Xiao W, Stinson JR, et al. Congenital B cell lymphocytosis explained by novel germline CARD11 mutations. J Exp Med 2012; 209:2247.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Darte JM, McClure PD, Saunders EF, et al. Congenital lymphoid hyperplasia with persistent hyperlymphocytosis. N Engl J Med 1971; 284:431.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sivakumaran M, Richards S. Immunological abnormalities of chronic large granular lymphocytosis. Clin Lab Haematol 1997; 19:57.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kaito K, Otsubo H, Ogasawara Y, et al. Severe aplastic anemia associated with chronic natural killer cell lymphocytosis. Int J Hematol 2000; 72:463.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Loughran TP Jr. Clonal diseases of large granular lymphocytes. Blood 1993; 82:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bockorny B, Dasanu CA. Autoimmune manifestations in large granular lymphocyte leukemia. Clin Lymphoma Myeloma Leuk 2012; 12:400.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pontikoglou C, Kalpadakis C, Papadaki HA. Pathophysiologic mechanisms and management of neutropenia associated with large granular lymphocytic leukemia. Expert Rev Hematol 2011; 4:317.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Liu X, Loughran TP Jr. The spectrum of large granular lymphocyte leukemia and Felty's syndrome. Curr Opin Hematol 2011; 18:254.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Castelino DJ, McNair P, Kay TW. Lymphocytopenia in a hospital population--what does it signify? Aust N Z J Med 1997; 27:170.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 8387 Version 38.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18798099" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Peripheral blood lymphocytosis--what is the threshold for further investigation?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18798107" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Using peripheral smear review, age and absolute lymphocyte count as predictors of abnormal peripheral blood lymphocytoses diagnosed by flow cytometry.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22658164" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : [Lymphocytopenia: aetiology and diagnosis, when to think about idiopathic CD4(+) lymphocytopenia?].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9643562" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : EBV-NK cells interactions and lymphoproliferative disorders.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10606874" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Flow cytometric detection of CD10 (cALLA) on peripheral blood B lymphocytes of neonates.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21079153" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Hematogones: a new prognostic factor for acute myeloblastic leukemia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20001239" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Hematogones: a review and update.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Acute lymphadenosis compared with acute lymphatic leukemia
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15541197" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Infectious mononucleosis and Epstein-Barr virus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23100562" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Behavioral, virologic, and immunologic factors associated with acquisition and severity of primary Epstein-Barr virus infection in university students.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3005799" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Clinical and laboratory evaluation of cytomegalovirus-induced mononucleosis in previously healthy individuals. Report of 82 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3394657" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Heterophil-negative mononucleosis-like illnesses with atypical lymphocytosis in patients undergoing seroconversions to the human immunodeficiency virus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3016618" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Mononucleosis-like-syndrome associated with acute AIDS retrovirus infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8499636" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Persistent polyclonal lymphocytosis in human immunodeficiency virus-1-infected patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2857899" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Acute AIDS retrovirus infection. Definition of a clinical illness associated with seroconversion.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2161178" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : The spectrum of clinical and laboratory findings resulting from human herpesvirus-6 (HHV-6) in patients with mononucleosis-like illnesses not resulting from Epstein-Barr virus or cytomegalovirus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/204189" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Heterophil-negative infectious mononucleosis and mononucleosis-like illnesses. Laboratory confirmation of 43 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4592097" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Toxoplasmosis in the adult.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2833099" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Human T-lymphotropic virus type I-associated benign transient immature T-cell lymphocytosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/631844" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : The circulating "atypical" lymphocyte.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Infectious lymphocytosis
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14074503" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : ACUTE INFECTIOUS LYMPHOCYTOSIS PRESENTING AS A PERTUSSIS-LIKE ILLNESS: ITS ASSOCIATION WITH ADENOVIRUS TYPE 12.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/303926" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Acute infectious lymphocytosis as a T-cell lymphoproliferative syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2042590" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : The morphologic and immunophenotypic assessment of the lymphocytosis accompanying Bordetella pertussis infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8036048" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Clinical characteristics of illness caused by Bordetella parapertussis compared with illness caused by Bordetella pertussis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22080463" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Question 3. Is measurement of the lymphocyte count useful in the investigation of suspected pertussis in infants?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22080463" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Question 3. Is measurement of the lymphocyte count useful in the investigation of suspected pertussis in infants?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22831461" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : A review on human toxoplasmosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7727662" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Atypical lymphocytosis in babesiosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22360483" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Current advances in detection and treatment of babesiosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20738828" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Transfusion-associated infections: 50 years of relentless challenges and remarkable progress.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22920398" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : HLA and pharmacogenetics of drug hypersensitivity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19563993" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : The variable clinical picture of drug-induced hypersensitivity syndrome/drug rash with eosinophilia and systemic symptoms in relation to the eliciting drug.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3632284" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Transient atypical lymphocytosis in patients with emergency medical conditions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17274042" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Which observations from the complete blood cell count predict mortality for hospitalized patients?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1642846" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : The redistribution of lymphocytes during adrenaline infusion. An in vivo study with radiolabelled cells.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2738972" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Acute lymphocytosis after trauma--early recognition of the high-risk patient?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2095748" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Transient stress lymphocytosis during crisis of sickle cell anemia and emergency trauma and medical conditions. An immunophenotyping study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7620211" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Lymphocyte subset redistribution in response to acute experimental stress: effects of gender, ethnicity, hypertension, and the sympathetic nervous system.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8697729" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Post-splenectomy lymphocytosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7734372" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Persistent lymphocytosis of natural killer cells in autoimmune thrombocytopenic purpura (ATP) patients after splenectomy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3708908" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Permanent large granular lymphocytosis in the blood of splenectomized individuals without concomitant increase of in vitro natural killer cell cytotoxicity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23129749" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Congenital B cell lymphocytosis explained by novel germline CARD11 mutations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5540480" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Congenital lymphoid hyperplasia with persistent hyperlymphocytosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9146949" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Immunological abnormalities of chronic large granular lymphocytosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11197212" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Severe aplastic anemia associated with chronic natural killer cell lymphocytosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8324214" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Clonal diseases of large granular lymphocytes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22999943" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Autoimmune manifestations in large granular lymphocyte leukemia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21668396" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Pathophysiologic mechanisms and management of neutropenia associated with large granular lymphocytic leukemia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21546829" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : The spectrum of large granular lymphocyte leukemia and Felty's syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9145181" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Lymphocytopenia in a hospital population--what does it signify?
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
